Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
28,893,785
-
Share change
-
-11,958,760
-
Total reported value
-
$7,628,584
-
Put/Call ratio
-
86%
-
Price per share
-
$0.26
-
Number of holders
-
44
-
Value change
-
-$3,666,548
-
Number of buys
-
20
-
Number of sells
-
41
Institutional Holders of iBio, Inc. - Common Stock (IBIO) as of Q2 2022
As of 30 Jun 2022,
iBio, Inc. - Common Stock (IBIO) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,893,785 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Ergoteles LLC, STATE STREET CORP, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and NORTHERN TRUST CORP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.